168 related articles for article (PubMed ID: 15068233)
1. Fatal hepatitis during Epstein-Barr virus reactivation.
Cacopardo B; Nunnari G; Mughini MT; Tosto S; Benanti F; Nigro L
Eur Rev Med Pharmacol Sci; 2003; 7(4):107-9. PubMed ID: 15068233
[TBL] [Abstract][Full Text] [Related]
2. Fulminant hepatitis due to Epstein-Barr virus infection.
Papatheodoridis GV; Delladetsima JK; Kavallierou L; Kapranos N; Tassopoulos NC
J Hepatol; 1995 Sep; 23(3):348-50. PubMed ID: 8551000
[TBL] [Abstract][Full Text] [Related]
3. [Polyclonal activation due to Epstein-Barr virus superinfection in a case with chronic hepatitis B].
Bakir Ozbey S; Mistik R; Gürcüoğlu E; Oral B; Göral G
Mikrobiyol Bul; 2007 Oct; 41(4):607-12. PubMed ID: 18173082
[TBL] [Abstract][Full Text] [Related]
4. Fulminant Epstein-Barr virus (EBV) hepatitis in a young immunocompetent subject.
Ader F; Chatellier D; Le Berre R; Morand P; Fourrier F
Med Mal Infect; 2006 Jul; 36(7):396-8. PubMed ID: 16876362
[TBL] [Abstract][Full Text] [Related]
5. [Fatal fulminant Epstein-Barr virus hepatitis].
Lazrek M; Boitrelle F; Dewilde A; Schanen C; Chopin C; Desreumaux P; Leteurtre E; Hober D
Ann Biol Clin (Paris); 2006; 64(2):170-2. PubMed ID: 16556529
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus acute encephalomyelitis in a 13-year-old boy.
Grillo E; da Silva RJ; Barbato Filho JH
Eur J Paediatr Neurol; 2008 Sep; 12(5):417-20. PubMed ID: 18054506
[TBL] [Abstract][Full Text] [Related]
7. Immunohistologic identification of Epstein-Barr virus-induced hepatitis reactivation after OKT-3 therapy following orthotopic liver transplant.
Markin RS; Wood RP; Shaw BW; Brichacek B; Purtilo DT
Am J Gastroenterol; 1990 Aug; 85(8):1014-8. PubMed ID: 2165351
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-associated meningoencephalomyelitis: intrathecal reactivation of the virus in an immunocompetent child.
Sanefuji M; Ohga S; Kira R; Nomura A; Torisu H; Takada H; Kusuhara K; Hara T
J Child Neurol; 2008 Sep; 23(9):1072-7. PubMed ID: 18827273
[TBL] [Abstract][Full Text] [Related]
9. [Epstein-Barr virus-associated hemophagocytic syndrome during mid-term pregnancy successfully treated with combined methylprednisolone and intravenous immunoglobulin].
Mihara H; Kato Y; Tokura Y; Hattori Y; Sato A; Kobayashi H; Imamura A; Daimaru O; Miwa H; Nitta M
Rinsho Ketsueki; 1999 Dec; 40(12):1258-64. PubMed ID: 10658479
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
Seishima M; Yamanaka S; Fujisawa T; Tohyama M; Hashimoto K
Br J Dermatol; 2006 Aug; 155(2):344-9. PubMed ID: 16882173
[TBL] [Abstract][Full Text] [Related]
11. Common variable immunodeficiency following Epstein-Barr virus infection.
Zuccaro G; Della Bella S; Polizzi B; Vanoli M; Scorza R
J Clin Lab Immunol; 1997; 49(1):41-5. PubMed ID: 9819672
[TBL] [Abstract][Full Text] [Related]
12. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
[TBL] [Abstract][Full Text] [Related]
13. Time course and frequency of Epstein-Barr virus reactivation after kidney transplantation: linkage to renal allograft rejection.
Jabs WJ; Maurmann S; Wagner HJ; Müller-Steinhardt M; Steinhoff J; Fricke L
J Infect Dis; 2004 Nov; 190(9):1600-4. PubMed ID: 15478064
[TBL] [Abstract][Full Text] [Related]
14. Haemolysis in hepatitis A virus infections coinciding with the occurrence of autoantibodies against triosephosphate isomerase and the reactivation of latent persistent Epstein-Barr virus infection.
Ritter S; Schröder S; Uy A; Ritter K
J Med Virol; 1996 Nov; 50(3):272-5. PubMed ID: 8923293
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr viral hepatitis: an unusual case and review of the literature.
Jacobson IM; Gang DL; Schapiro RH
Am J Gastroenterol; 1984 Aug; 79(8):628-32. PubMed ID: 6087655
[TBL] [Abstract][Full Text] [Related]
16. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
Stevens SJ; Smits PH; Verkuijlen SA; Rockx DA; van Gorp EC; Mulder JW; Middeldorp JM
AIDS; 2007 Oct; 21(16):2141-9. PubMed ID: 18090040
[TBL] [Abstract][Full Text] [Related]
17. Incidence of reactive antibodies against epstein-barr in a group of renal transplant patients.
Geramizadeh B; Aghdai M; Azarpira N; Behabahani AB; Heidari T; Banihashemi M; Raisjalali AR; Roozbeh J; Behzadi A
Transplant Proc; 2005 Sep; 37(7):3051-2. PubMed ID: 16213301
[TBL] [Abstract][Full Text] [Related]
18. Frosted branch angiitis associated with Epstein-Barr virus systemic infection.
Farrando J; Fonollosa A; Segura A; Garcia-Arumi J
Ocul Immunol Inflamm; 2008; 16(1):41-3. PubMed ID: 18379942
[TBL] [Abstract][Full Text] [Related]
19. Ascites and severe hepatitis complicating Epstein-Barr infection.
Devereaux CE; Bemiller T; Brann O
Am J Gastroenterol; 1999 Jan; 94(1):236-40. PubMed ID: 9934763
[TBL] [Abstract][Full Text] [Related]
20. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection.
Hara S; Hoshino Y; Naitou T; Nagano K; Iwai M; Suzuki K; Yamamoto K; Nagasaka T; Morishima T; Kimura H
J Clin Virol; 2006 Mar; 35(3):250-6. PubMed ID: 16181807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
